BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37568783)

  • 1. Potential of miRNAs in Plasma Extracellular Vesicle for the Stratification of Prostate Cancer in a South African Population.
    Temilola DO; Wium M; Paccez J; Salukazana AS; Otu HH; Carbone GM; Kaestner L; Cacciatore S; Zerbini LF
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers.
    Worst TS; Previti C; Nitschke K; Diessl N; Gross JC; Hoffmann L; Frey L; Thomas V; Kahlert C; Bieback K; Crigna AT; Fricke F; Porubsky S; Westhoff N; Hardenberg JV; Nuhn P; Erben P; Michel MS; Boutros M
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Analysis of Tissue-Derived and Biofluid Extracellular Vesicle miRNAs Associated with Prostate Cancer.
    Larson J; Ozen MO; Kohli M; Akin D; Demirci U
    Adv Biol (Weinh); 2023 Jul; 7(7):e2200327. PubMed ID: 37300338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
    Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
    Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential plasma microRNAs signature miR-190b-5p, miR-215-5p and miR-527 as non-invasive biomarkers for prostate cancer.
    Khan MM; Serajuddin M; Bharadwaj M
    Biomarkers; 2023 Mar; 28(2):227-237. PubMed ID: 36644827
    [No Abstract]   [Full Text] [Related]  

  • 8. miR-20b-5p is a novel biomarker for detecting prostate cancer.
    Zhai TY; Dou M; Ma YB; Wang H; Liu F; Zhang LD; Chong T; Wang ZM; Xue L
    Oncol Lett; 2022 Dec; 24(6):426. PubMed ID: 36311688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.
    Dong L; Hu C; Ma Z; Huang Y; Shelley G; Kuczler MD; Kim CJ; Witwer KW; Keller ET; Amend SR; Xue W; Pienta KJ
    Res Sq; 2024 Mar; ():. PubMed ID: 38585988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia.
    Ge Y; Wang Q; Shao W; Zhao Y; Shi Q; Yuan Q; Cui L
    J Cancer; 2020; 11(15):4542-4549. PubMed ID: 32489471
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.
    Dong L; Hu C; Ma Z; Huang Y; Shelley G; Kuczler MD; Kim CJ; Witwer KW; Keller ET; Amend SR; Xue W; Pienta KJ
    Med Oncol; 2024 Jun; 41(7):169. PubMed ID: 38839666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification.
    Al-Kafaji G; Said HM; Alam MA; Al Naieb ZT
    Oncol Lett; 2018 Jul; 16(1):1357-1365. PubMed ID: 30061955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small RNA sequencing of extracellular vesicles identifies circulating miRNAs related to inflammation and oxidative stress in HIV patients.
    Chettimada S; Lorenz DR; Misra V; Wolinsky SM; Gabuzda D
    BMC Immunol; 2020 Nov; 21(1):57. PubMed ID: 33176710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.
    Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Cybulska M; Szymanski M; Dobruch J; Antoniewicz A; Mikula M; Ostrowski J
    Biomed Res Int; 2020; 2020():9086829. PubMed ID: 32462034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and identification of extracellular vesicles-coupled miRNA profiles in seminal plasma of fertile and subfertile rabbit bucks.
    Sakr OG; Gad A; Cañón-Beltrán K; Cajas YN; Prochazka R; Rizos D; Rebollar PG
    Theriogenology; 2023 Oct; 209():76-88. PubMed ID: 37364341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
    Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
    Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
    Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
    Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer.
    Juracek J; Madrzyk M; Stanik M; Ruckova M; Trachtova K; Malcikova H; Lzicarova E; Barth DA; Pichler M; Slaby O
    Prostate; 2023 Mar; 83(4):340-351. PubMed ID: 36478451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seminal plasma microRNAs improve diagnosis/prognosis of prostate cancer in men with moderately altered prostate-specific antigen.
    Barceló M; Castells M; Pérez-Riba M; Bassas L; Vigués F; Larriba S
    Am J Transl Res; 2020; 12(5):2041-2051. PubMed ID: 32509198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.